REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma-Maac D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharma-Maac D.O.O. Beograd Profile Updated: August 26, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pharma-Maac D.O.O. Beograd is based in Serbia, with the head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on November 30, 2011. The total number of employees is currently 27 (2025). The company’s latest financial report indicates a net sales revenue increase of 21.12% in 2025. Its’ total assets recorded a growth of 21.3%. Pharma-Maac D.O.O. Beograd’s net profit margin decreased by 0.18% in 2025.

Headquarters
Makenzijeva 67
Belgrade; Belgrade;

Contact Details: Purchase the Pharma-Maac D.O.O. Beograd report to view the information.

Website: http://www.pharmamaac.rs

Basic Information
Total Employees:
Purchase the Pharma-Maac D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Pharma-Maac D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Pharma-Maac D.O.O. Beograd report to view the information.
Incorporation Date:
November 30, 2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
97.66%
Purchase this report to view the information.
2.34%
Company Performance
Financial values in the chart are available after Pharma-Maac D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
21.12%▲
Total Operating Revenue
21.14%▲
Operating Profit
20.34%▲
EBITDA
20.2%▲
Net Profit/Loss for the Period
20.44%▲
Total Assets
21.3%▲
Total Equity
33.99%▲
Operating Profit Margin
-0.25%▼
Net Profit Margin
-0.18%▼
Return on Equity (ROE)
-3.22%▼
Debt / Equity
-0.01%▼
Quick Ratio
1.49%▲
Cash Ratio
-2.01%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?